Dogwood Therapeutics (DWTX) Other Non-Current Liabilities (2024)

Dogwood Therapeutics has reported Other Non-Current Liabilities for 1 years, with the latest figure at $15.4 million in Q4 2024.

• On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $15.4 million in Q4 2024; TTM through Dec 2024 was $15.4 million, a N/A change from a year earlier, with the FY2024 full-year figure at $15.4 million, changed N/A from the prior year.
• Other Non-Current Liabilities was $15.4 million for Q4 2024 at Dogwood Therapeutics.
• The five-year high for Other Non-Current Liabilities was $15.4 million in Q4 2024, with the low at $15.4 million in Q4 2024.